CN104225286A - Traditional Chinese medicine preparation for treating hypertension and preventing stroke and preparation method of traditional Chinese medicine preparation - Google Patents

Traditional Chinese medicine preparation for treating hypertension and preventing stroke and preparation method of traditional Chinese medicine preparation Download PDF

Info

Publication number
CN104225286A
CN104225286A CN201310250170.0A CN201310250170A CN104225286A CN 104225286 A CN104225286 A CN 104225286A CN 201310250170 A CN201310250170 A CN 201310250170A CN 104225286 A CN104225286 A CN 104225286A
Authority
CN
China
Prior art keywords
chinese medicine
traditional chinese
preparation
medicine preparation
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310250170.0A
Other languages
Chinese (zh)
Inventor
晋鲁妍
顾雅娴
况成裕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANDONG MINGREN FURUIDA PHARMACEUTICAL Co Ltd
Original Assignee
SHANDONG MINGREN FURUIDA PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANDONG MINGREN FURUIDA PHARMACEUTICAL Co Ltd filed Critical SHANDONG MINGREN FURUIDA PHARMACEUTICAL Co Ltd
Priority to CN201310250170.0A priority Critical patent/CN104225286A/en
Publication of CN104225286A publication Critical patent/CN104225286A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine preparation for treating hypertension and preventing a stroke and a preparation method of the traditional Chinese medicine preparation. The invention relates to a traditional Chinese medicine preparation for treating hypertension and preventing the stroke. The traditional Chinese medicine preparation is characterized by comprising the traditional Chinese medicine components for tonifying qi and invigorating the circulation of blood, removing heat from the liver and removing stasis, clearing and activating the channels and collaterals, and strengthening the heart and tonifying the bones, wherein the traditional Chinese medicine components comprise eucommia ulmoides, selfheal, root of kudzu vine, scutellaria baicalensis, uncaria rhynchophylla, concha haliotidis, salviae miltiorrhizae, sunflower leaf, corn stigma, a folium ginkgo extract, and a rhodiola rosea extract. The medicine prepared by the method is capable of effectively reducing blood pressure, modulating blood fat and blood viscosity, preventing atherogenesis, and preventing stroke and coronary heart disease, and is capable of obviously improving the symptoms of the patient with hypertension, such as thirst and dizziness, headache, limb numbness, tinnitus, insomnia, weakness and the like, reducing blood pressure of the patient, and improving the myocardial function by clinical observation; the total effective rate reaches 90%; no obvious adverse reaction is found out; and the clinical effect is satisfying.

Description

A kind ofly treat Chinese medicine preparation of hypertension prevention apoplexy and preparation method thereof
Technical field
The present invention relates to a kind of Chinese medicine preparation, particularly a kind of Chinese medicine preparation its preparation method for the treatment of hypertension prevention apoplexy.
Background technology
Hypertension is a kind of common epidemic diseases, and day by day the accelerating of modern society's rhythm of life, the continuous increase of operating pressure, weather improve, and makes hypertensive ill probability in ascendant trend year by year.According to survey data in 2002, China's more than 18 years old adult hypertension prevalence was 18.8%, estimates that about there are 200,000,000 hyperpietics in current China, just has 2 people to suffer from hypertension, account for 1/5 of global hypertension total number of persons in every 10 adults.In China's Hypertensive Population, the overwhelming majority is light, moderate hypertension (accounting for 90%), and mild hypertension accounts for more than 60%.But population of China normal arterial pressure (<120/80mmHg) proportion is less than 1/2.The ratio that the horizontal crowd of In Prehypertensive accounts for total Adult Groups constantly increases, especially young and middle-aged, has been increased to 34% in 2002 from 29% in 1991, is that China's Prevalence of Hypertension continues to raise and the main source of number of patients sharp increase.Estimate China newly-increased hyperpietic 1,000 ten thousand people every year.According to investigations, population of China hypertension awareness is 30.2%, and treatment rate is 24.7%, and control rate is 6.1%.Hyperpietic can not get good control for a long time because of blood pressure, make large artery trunks and arteriolar degeneration, sclerosis, after one's own heart, brain, kidney, optical fundus and peripheral arterial sclerosis, cause the infringement of respective target organ, thus cause coronary heart disease, hypertensive heart disease (seriously can cause heart failure), apoplexy, hypertensive nephropathy (seriously can cause renal failure), optical fundus is oozed out, hemorrhagely cause visual deterioration, the disease such as blind.Research shows that population of China blood pressure level is from 110/75mmHg, along with blood pressure level rising, cardiovascular morbidity danger continues to increase, compare with blood pressure <110/75mmHg, during blood pressure 120 ~ 129/80 ~ 84mmHg, cardiovascular morbidity danger increases by 1 times, blood 140 ~ 149/90 ~ 94mmHg, and cardiovascular morbidity danger increases by 2 times, during blood pressure >180/110mmHg, cardiovascular morbidity danger increases by 10 times.The heart failure danger of the person that has hypertension history is than high 6 times without hypertension history person.Baseline systolic pressure often raises 10mmHg, and apoplexy generation relative risk increases 49%(Ischemic Stroke and increases by 47%, and hemorrhagic apoplexy increases by 54%); Diastolic pressure often raises 5mmHg, and Stroke risk increases by 46%.Positive control hypertension is the important measures of preventing brain stroke, coronary heart disease.
The present invention is attended by the patient of the symptoms such as dizziness, headache, limb fiber crops, tinnitus for hypertension and establishes just, there is inrigorating qi and promoting blood circulation, effect that liver heat removing eliminating stagnation, dredge the meridian passage, heart tonifying are good for bone, can effectively lowly reduce blood pressure, and energy regulating blood lipoid and blood stickiness, atherosclerosis formation, preventing brain stroke, coronary heart disease.
By clinical observation, the present invention obviously can improve that hypertension one thirsty is dizzy, headache, limb fiber crops, tinnitus, the nervous symptom such as weak.Reduce patient blood, improve myocardial function: total effective rate reaches 90%, and do not find any obvious untoward reaction, clinical effectiveness is satisfied.At present, clinically to evident in efficacy, safety good, Chinese medicine preparation easy to use still for be badly in need of.After being contrasted by the similar medicine of the present invention and existing treatment hypertension and complication thereof, we think that curative effect of the present invention is reliable, and have one's own knack on prescription medicine, are the crystallizations of clinical experience for many years.Therefore, exploitation of the present invention is expected to provide a safety, ideal Chinese medicine preparation effective, cheap, easy to use for clinical, is expected to obtain good economical, societal benefits after applying.
Summary of the invention
The invention belongs to a kind of Chinese medicine preparation for the treatment of hypertension prevention apoplexy, it is characterized in that inrigorating qi and promoting blood circulation, liver heat removing eliminating stagnation, dredge the meridian passage, the Chinese prescription of bone and muscle strengthening forms, comprise the Cortex Eucommiae (12-36%), Spica Prunellae (8-25%), Radix Puerariae (14-30%), Radix Scutellariae (3-25%), Ramulus Uncariae Cum Uncis (5-25%), Concha Haliotidis (6-25%), Radix Salviae Miltiorrhizae (5-25%), Folium Helianthi (5-26%), Stigma Maydis (8-28%), Folium Ginkgo extract (0.1-1.5%), Radix Rhodiolae extract (0.2-2%).
Technical scheme of the present invention is: extract taste Chinese medicine each in the present invention, extracting solution concentrating under reduced pressure becomes concentrated solution; After concentrated solution is dried to extraction dry powder by distinct methods, by adding different auxiliary material respectively, can be made into the solid preparations such as granule, capsule, tablet; Can also will add appropriate distilled water in concentrated solution, water precipitating adds adjuvant and oral liquid made by antiseptic after filtering; Instill after concentrated solution can also being added proper amount of matrix mixing in condensed fluid, shrink cooling and make drop pill.The different auxiliary material that different dosage form of the present invention adds, does not affect clinical effectiveness of the present invention, and these adjuvants comprise the starch, microcrystalline Cellulose, magnesium stearate, dextrin, lactose, oligomeric xylose, antiseptic etc. that diabetes patient is suitable for.Therefore the present invention can meet the requirement of diabetics to different dosage form.
The object of this invention is to provide and a kind ofly treat the Chinese medicine preparation that hypertension prevention apoplexy has obvious curative effects and control action.The Pharmacodynamics experimental result of this preparation shows: this preparation can make hypertension symptom obviously improve, and reduces cardiovascular and cerebrovascular vessel resistance simultaneously, and all has no adverse effect to Heart Rate, liver function, electrocardiogram indices.Use Granules in Treating hyperpietic 20 of the present invention example clinically, basic recovery 5 example, account for 25%, marked improvement 9 example, accounts for 45%, progressive 4 examples, 20%, total effective rate 90%.Tcm symptom improves total effective rate: blood pressure reduces and stablizes 91.97%, and dizzy 77.8%, limb fiber crops 87.1%, cardiopalmus 76.78%, hyperhidrosis 80.15%, complexion 83%.Illustrate that the present invention obviously can improve hypertension symptom.Compare P<0.001 before and after the treatment of tcm symptom total mark value and have significant differences.13.85 ± 6.82 days average onset times, the shortest 5 days, most elder 21 days.After treatment, blood pressure has obvious decline (equal P<0.001).Also observe the impact of granule of the present invention on the safety indexes of liver, kidney, cardiac function in clinical experiment process simultaneously, find Non Apparent Abnormality change before and after treatment.Clinical taking in process has not reported gastrointestinal tract and other untoward reaction yet, illustrates that the present invention takes safety.
Prescription of the present invention, on the basis of above-mentioned ten Herba indigoferae Pseudotinctoriae, can also add other and have blood sugar lowering inrigorating qi and promoting blood circulation, the Chinese medicine of soothing the liver dissipating blood stasis.
Using method of the present invention: oral, every day three times, each 1-2 bag granule (or 2-4 capsules, or 2-4 sheet tablet, or 1-2 props up oral liquid, or 1-2 drop pill).It within 30 days, is a course for the treatment of.
embodiment 1
get Radix Scutellariae 320g, Stigma Maydis 360g decocts with water 2 times, each 2 hours, merge extractive liquid, filtered, filtrate concentrates, adding ethanol in concentrated solution makes alcohol content reach 60%, precipitate with ethanol, cold preservation (-2 ~ 2 DEG C) 24 hours, filter, filtrate recycling ethanol and to be condensed into relative density be 1.22 ~ 1.23(60 DEG C) concentrated solution; Get Cortex Eucommiae 700g again, Radix Puerariae 600g, Ramulus Uncariae Cum Uncis 200g, Radix Salviae Miltiorrhizae 360g, Spica Prunellae 120g, Concha Haliotidis 160g, Folium Helianthi 280g, add 60% ethanol extraction secondary, 2 hours first times, second time 1 hour, merge extractive liquid, filter, filtrate recycling ethanol, and the concentrated solution being condensed into that relative density is 1.21 ~ 1.22; Separately get Folium Ginkgo extract 4.6g, Radix Rhodiolae extract 5.3g, is ground into fine powder, sieves, mixing.Get above-mentioned two kinds of concentrated solutions, merge, continue to be condensed into thick paste, dry, pulverize, add above-mentioned fine powder, evenly sieve, be the dry medicated powder of extraction of the present invention; Or get above-mentioned two kinds of concentrated solutions merging, add above-mentioned fine powder, add 200ml distilled water and make dissolving, water precipitating (-2 ~ 2 DEG C) 24 hours, filter, filtrate is the present invention and extracts medicinal liquid.
embodiment 2get Radix Scutellariae 360g, Stigma Maydis 380g decocts with water 2 times, each 2 hours, merge extractive liquid, filtered, filtrate concentrates, adding ethanol in concentrated solution makes alcohol content reach 70%, precipitate with ethanol, cold preservation (-2 ~ 2 DEG C) 24 hours, filter, filtrate recycling ethanol and to be condensed into relative density be 1.22 ~ 1.23(60 DEG C) concentrated solution; Get Cortex Eucommiae 900g again, Radix Puerariae 800g, Ramulus Uncariae Cum Uncis 220g, Radix Salviae Miltiorrhizae 280g, Spica Prunellae 140g, Concha Haliotidis 180g, Folium Helianthi 320g, add 70% ethanol extraction secondary, 2 hours first times, second time 1 hour, merge extractive liquid, filter, filtrate recycling ethanol, and the concentrated solution being condensed into that relative density is 1.21 ~ 1.22; Separately get Folium Ginkgo extract 6.2g, Radix Rhodiolae extract 6.9g, is ground into fine powder, sieves, mixing.Get above-mentioned two kinds of concentrated solutions, merge, continue to be condensed into thick paste, dry, pulverize, add above-mentioned fine powder, evenly sieve, be the dry medicated powder of extraction of the present invention; Or get above-mentioned two kinds of concentrated solutions merging, add above-mentioned fine powder, add 300ml distilled water and make dissolving, water precipitating (-2 ~ 2 DEG C) 24 hours, filter, filtrate is the present invention and extracts medicinal liquid.
embodiment 3
Get Radix Scutellariae 380g, Stigma Maydis 320g decocts with water 2 times, each 2 hours, merge extractive liquid, filtered, filtrate concentrates, adding ethanol in concentrated solution makes alcohol content reach 75%, precipitate with ethanol, cold preservation (-2 ~ 2 DEG C) 24 hours, filter, filtrate recycling ethanol and to be condensed into relative density be 1.22 ~ 1.23(60 DEG C) concentrated solution; Get Cortex Eucommiae 800g again, Radix Puerariae 820g, Ramulus Uncariae Cum Uncis 240g, Radix Salviae Miltiorrhizae 240g, Spica Prunellae 160g, Concha Haliotidis 140g, Folium Helianthi 360g, add 80% ethanol extraction secondary, 2 hours first times, second time 1 hour, merge extractive liquid, filter, filtrate recycling ethanol, and the concentrated solution being condensed into that relative density is 1.21 ~ 1.22; Separately get Folium Ginkgo extract 3.8g, Radix Rhodiolae extract 8.5g, is ground into fine powder, sieves, mixing.Get above-mentioned two kinds of concentrated solutions, merge, continue to be condensed into thick paste, dry, pulverize, add above-mentioned fine powder, evenly sieve, be the dry medicated powder of extraction of the present invention; Or get above-mentioned two kinds of concentrated solutions merging, add above-mentioned fine powder, add 500ml distilled water and make dissolving, water precipitating (-2 ~ 2 DEG C) 24 hours, filter, filtrate is the present invention and extracts medicinal liquid.
embodiment 4: tablet
Add 130g starch, 20g microcrystalline Cellulose by the various embodiments described above in the dry medicated powder of any extract, mixing, granulate, dry, sieve, add 1.5g magnesium stearate, mixing, is pressed into 1000 and is Tablets.
embodiment 5: capsule
Add 180g starch by the various embodiments described above in the dry medicated powder of any extract, mixing, granulate, dry, sieve, fill 1000 capsules, be capsule of the present invention.
embodiment 6: granule
Add lactose 180g, dextrin 600g by the various embodiments described above in the dry medicated powder of any extract, granulate, granulate, sieves, and makes 1000g granule, is granule of the present invention.
embodiment 7: oral liquid
Add 0.3% sodium benzoate, 400ml distilled water by the various embodiments described above in the dry medicated powder of any extract, sterilization, fill, makes 1000ml oral liquid, is oral liquid of the present invention.
According to formula of the present invention, the preparation of other dosage forms such as suspensoid, drop pill, syrup can also be made.
Hypertension is one of China's frequently-occurring disease, and in China's Hypertensive Population, the overwhelming majority is light, moderate hypertension (accounting for 90%), and mild hypertension accounts for more than 60%.But population of China normal arterial pressure (<120/80mmHg) proportion is less than 1/2.The ratio that the horizontal crowd of In Prehypertensive accounts for total Adult Groups constantly increases.According to investigations, population of China hypertension awareness is 30.2%, and treatment rate is 24.7%, and control rate is 6.1%.Hyperpietic can not get good control for a long time because of blood pressure, make large artery trunks and arteriolar degeneration, sclerosis, after one's own heart, brain, kidney, optical fundus and peripheral arterial sclerosis, cause the infringement of respective target organ, thus cause coronary heart disease, hypertensive heart disease (seriously can cause heart failure), apoplexy, hypertensive nephropathy (seriously can cause renal failure), optical fundus is oozed out, hemorrhagely cause visual deterioration, the disease such as blind.Family of the present invention acts on and surmounts hypertension center mode, reduce blood pressure with
Inrigorating qi and promoting blood circulation, liver heat removing eliminating stagnation, dredge the meridian passage develop simultaneously, and can effectively lowly reduce blood pressure, and energy regulating blood lipoid and blood stickiness, atherosclerosis formation, preventing brain stroke, coronary heart disease, from Chinese medical discrimination theory, TCM theory links closely pathogenesis, giving consideration to both the incidental and fundamental, and flavour of a drug refine, compatibility is orderly, and medicine letter power is special, is treatment hypertension, improve cardiovascular and cerebrovascular vessel health status, the good recipe of preventing brain stroke, coronary heart disease.
Development of the present invention is faced with wide market, wherein contains great social benefit and huge economic benefit.

Claims (4)

1. treat a Chinese medicine preparation for hypertension prevention apoplexy, it is characterized in that said preparation is made up of following raw material; The Cortex Eucommiae, Spica Prunellae, Radix Puerariae, Radix Scutellariae, Ramulus Uncariae Cum Uncis, Concha Haliotidis, Radix Salviae Miltiorrhizae, Folium Helianthi, Stigma Maydis, Folium Ginkgo extract, Radix Rhodiolae extract.
2. there is the Chinese medicine preparation for the treatment of hypertension prevention apoplexy as claimed in claim 1, it is characterized in that each Ingredient Amount is respectively: Cortex Eucommiae 12-36%, Spica Prunellae 8-25%, Radix Puerariae l4-30%, Radix Scutellariae 3-25%, Ramulus Uncariae Cum Uncis 5-25%, Concha Haliotidis 6-25%, Radix Salviae Miltiorrhizae 5-25%, Folium Helianthi 5-26%, Stigma Maydis 8-28%, Folium Ginkgo extract 0.1-1.5%, Radix Rhodiolae extract 0.2-2%.
3. the Chinese medicine preparation with treatment hypertension prevention apoplexy as described in claim 1,2, it is characterized in that making Chinese patent medicine, dosage form is the preparations such as oral tablet, granule, capsule, oral liquid, drop pill.
4. the preparation method with the Chinese medicine preparation for the treatment of hypertension prevention apoplexy as described in claim 1,2,3; it is characterized in that the technological process of described preparation is: get Radix Scutellariae, Stigma Maydis, decoct with water 2 times, each 2 hours; merge extractive liquid; filter, filtrate concentrates, and adds ethanol and make alcohol content reach 60 ~ 75% in concentrated solution; precipitate with ethanol; cold preservation 24 hours, filter, filtrate recycling ethanol is also condensed into the concentrated solution that relative density is 1.22 ~ 1.23; Get the Cortex Eucommiae, Radix Puerariae, Ramulus Uncariae Cum Uncis, Radix Salviae Miltiorrhizae, Spica Prunellae again, Concha Haliotidis, Folium Helianthi, add 60 ~ 80% ethanol extraction secondaries; 2 hours first times, second time 1 hour, merge extractive liquid; filter, filtrate recycling ethanol, and the concentrated solution being condensed into that relative density is 1.21 ~ 1.22; Separately get Folium Ginkgo extract, Radix Rhodiolae extract, be ground into fine powder, sieve, mixing.Get above-mentioned two kinds of concentrated solutions, merge, continue to be condensed into thick paste, dry, pulverize, add above-mentioned fine powder, evenly sieve, be the dry medicated powder of extraction of the present invention; Or get above-mentioned two kinds of concentrated solutions merging, add above-mentioned fine powder, add 200 ~ 500ml distilled water and make dissolving, water precipitating 24 hours, filter, filtrate is the present invention and extracts medicinal liquid.By adding starch, dextrin, microcrystalline Cellulose, magnesium stearate, lactose, oligomeric xylose, antiseptic adjuvant, make granule, capsule, tablet, oral liquid, drop pill.
CN201310250170.0A 2013-06-24 2013-06-24 Traditional Chinese medicine preparation for treating hypertension and preventing stroke and preparation method of traditional Chinese medicine preparation Pending CN104225286A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310250170.0A CN104225286A (en) 2013-06-24 2013-06-24 Traditional Chinese medicine preparation for treating hypertension and preventing stroke and preparation method of traditional Chinese medicine preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310250170.0A CN104225286A (en) 2013-06-24 2013-06-24 Traditional Chinese medicine preparation for treating hypertension and preventing stroke and preparation method of traditional Chinese medicine preparation

Publications (1)

Publication Number Publication Date
CN104225286A true CN104225286A (en) 2014-12-24

Family

ID=52214762

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310250170.0A Pending CN104225286A (en) 2013-06-24 2013-06-24 Traditional Chinese medicine preparation for treating hypertension and preventing stroke and preparation method of traditional Chinese medicine preparation

Country Status (1)

Country Link
CN (1) CN104225286A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105343596A (en) * 2015-11-13 2016-02-24 王丽 Pharmaceutical preparation for controlling atherosclerosis and its application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1314433A1 (en) * 2001-11-23 2003-05-28 Cognis Iberia, S.L. Process of preparation of extracts from Ginkgo biloba
CN1977876A (en) * 2005-11-29 2007-06-13 杨石 Medicinal composition containing rhodiola and ginkgo leaf, and its use
CN102430056A (en) * 2010-09-29 2012-05-02 杨晓杰 Medicament for treating hypertension

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1314433A1 (en) * 2001-11-23 2003-05-28 Cognis Iberia, S.L. Process of preparation of extracts from Ginkgo biloba
CN1977876A (en) * 2005-11-29 2007-06-13 杨石 Medicinal composition containing rhodiola and ginkgo leaf, and its use
CN102430056A (en) * 2010-09-29 2012-05-02 杨晓杰 Medicament for treating hypertension

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
吴存莉等: "丹菊葛芩汤治疗老年高血压病60例", 《陕西中医》 *
杨瑞龙等: "复方杜仲片治疗高血压病疗效观察", 《中国中医药信息杂志》 *
石增成等: "《高血压健康教育指南》", 30 June 2007 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105343596A (en) * 2015-11-13 2016-02-24 王丽 Pharmaceutical preparation for controlling atherosclerosis and its application

Similar Documents

Publication Publication Date Title
CN103948800A (en) Capsule for preventing chill after anesthesia and preparation method thereof
CN101559152B (en) Chinese materia medica preparation for treating hydrocephalus and preparation method thereof
CN103495063A (en) Traditional Chinese medicine preparation for treating icteric hepatitis as well as preparation method thereof
CN103356952B (en) Chinese medicine composition for treating arrhythmia
CN104225286A (en) Traditional Chinese medicine preparation for treating hypertension and preventing stroke and preparation method of traditional Chinese medicine preparation
CN102133288A (en) Chinese herba preparation for curing angina
CN103920058A (en) Traditional Chinese medicine preparation for treating headache and preparation method thereof
CN103933356A (en) Preoperative intervention medicine composition for neurosurgery and preparation method of composition
CN104721556A (en) Traditional Chinese medicine used for treating oral ulcer
CN102293855A (en) Chinese medicinal composition for treating speech and kidney deficiency diabetic nephropathy, and preparation method and application thereof
CN104225219A (en) Traditional Chinese medicine preparation for reducing blood fat and softening blood vessels and preparation method of traditional Chinese preparation
CN103127413B (en) Pharmaceutical preparation for treating coronary diseases
CN108186758A (en) A kind of Chinese medicine composition of qi and activate blood circulation and preparation method thereof
CN107137683A (en) A kind of medicine for treating apoplexy and application
CN104208603A (en) Traditional Chinese medicine for treating diabetes and preventing cardio-cerebrovascular complications and preparation method thereof
CN103006998B (en) Medicine for treating acute glomerulonephritis (AGN) hypertensive crisis
CN102423354A (en) Traditional Chinese medicine for treating hypertension
CN1245184C (en) Insomnia treating traditional Chinese medicine preparation and its preparing process
CN104258110B (en) A kind of Chinese medicine for treating cardioneurosis
CN1245180C (en) Hypertension treating traditional Chinese medicine preparation and its preparing process
CN104906360A (en) Traditional Chinese medicine compound capable of nourishing Yin and promoting blood circulation
CN104840551A (en) Hypertension relieving mulberry leaf Chinese medicine preparation and preparing method
CN105709010A (en) Pharmaceutical composition having blood-sugar reducing assisting function
CN103127400B (en) Drug for treatment of anxiety disorder and preparation method thereof
CN104825809A (en) Medicament for treating peripheral facial paralysis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141224